Repros Therapeutics Inc (NASDAQ:RPRX)

During the Trading Day
8.54 -0.03 / -0.35%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.54 0.00 / 0.00%
Volume: 2.9K
Health Technology
Medical Specialties

Company Description

Repros Therapeutics, Inc. is a development stage biopharmaceutical company focused on the development of small molecule drugs for major unmet medical needs that treat male and female reproductive disorders. The company's current product pipeline consists of Androxal, Proellex, Vasomax and Z-Max. Repros Therapeutics was founded on August 28, 1987 and is headquartered in Woodlands, TX.

Contact Information

Repros Therapeutics, Inc.
2408 Timberloch Place
Woodlands Texas 77380
P:(281) 719-3400
Investor Relations:



Individual stakeholders9.21%
Other institutional43.43%
Mutual fund holders25.25%

Top Executives

Joseph S. PodolskiPresident, Chief Executive Officer & Director
Katherine A. AndersonSecretary, Chief Financial & Accounting Officer
Ronald D. WiehleVice President-Research & Development
Jaye L. ThompsonSenior Vice President-Clinical & Regulatory
Joachim F. WernickeChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account